FRSX Q3 2021 Earnings EPS Surprises Positive Amid PreRevenue Development Stage VELO Q1 2026 Earnings Significant EPS Beat Drives Stock Surge Lufax Q3 2024 Earnings Massive EPS Miss Highlights Persistent Headwinds Lyell Immunopharma LYEL Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline Nomad Foods Q1 2026 Earnings EPS Surprises 214 Above Estimates Amid Weaker Stock Reaction Avita Medical Q1 2026 Earnings EPS Miss Clouds Progress Stock Gains